SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-039534
Filing Date
2017-06-15
Accepted
2017-06-15 16:04:20
Documents
5
Period of Report
2017-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-15056_48k.htm 8-K 40594
2 EX-1.1 a17-15056_4ex1d1.htm EX-1.1 216584
3 EX-5.1 a17-15056_4ex5d1.htm EX-5.1 22144
4 EX-99.1 a17-15056_4ex99d1.htm EX-99.1 14547
5 GRAPHIC g150564kki001.jpg GRAPHIC 7589
  Complete submission text file 0001104659-17-039534.txt   305606
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 17913559
SIC: 2834 Pharmaceutical Preparations